DE69104481T2 - Imidazo[4,5-c]pyridine als paf antagonisten. - Google Patents

Imidazo[4,5-c]pyridine als paf antagonisten.

Info

Publication number
DE69104481T2
DE69104481T2 DE69104481T DE69104481T DE69104481T2 DE 69104481 T2 DE69104481 T2 DE 69104481T2 DE 69104481 T DE69104481 T DE 69104481T DE 69104481 T DE69104481 T DE 69104481T DE 69104481 T2 DE69104481 T2 DE 69104481T2
Authority
DE
Germany
Prior art keywords
imidazo
pyridine
paf antagonist
paf
antagonist
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69104481T
Other languages
English (en)
Other versions
DE69104481D1 (de
Inventor
Anthony Marfat
James Eggler
Kevin Cooper
Michael FRAY
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of DE69104481D1 publication Critical patent/DE69104481D1/de
Application granted granted Critical
Publication of DE69104481T2 publication Critical patent/DE69104481T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
DE69104481T 1990-05-09 1991-05-01 Imidazo[4,5-c]pyridine als paf antagonisten. Expired - Fee Related DE69104481T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52119990A 1990-05-09 1990-05-09
PCT/US1991/002997 WO1991017163A1 (en) 1990-05-09 1991-05-01 IMIDAZO (4,5-c) PYRIDINES WITH PAF ANTAGONIST ACTIVITY

Publications (2)

Publication Number Publication Date
DE69104481D1 DE69104481D1 (de) 1994-11-10
DE69104481T2 true DE69104481T2 (de) 1995-02-09

Family

ID=24075786

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69104481T Expired - Fee Related DE69104481T2 (de) 1990-05-09 1991-05-01 Imidazo[4,5-c]pyridine als paf antagonisten.

Country Status (27)

Country Link
EP (1) EP0533695B1 (de)
JP (1) JPH0678340B2 (de)
CN (1) CN1057839A (de)
AP (1) AP224A (de)
AT (1) ATE112567T1 (de)
AU (1) AU642265B2 (de)
BR (1) BR9106433A (de)
CA (1) CA2080476A1 (de)
DE (1) DE69104481T2 (de)
DK (1) DK0533695T3 (de)
ES (1) ES2061247T3 (de)
FI (1) FI925053A (de)
GT (1) GT199100031A (de)
HU (1) HUT62894A (de)
IE (1) IE911553A1 (de)
IL (1) IL98075A0 (de)
MA (1) MA22151A1 (de)
MY (1) MY105512A (de)
NO (1) NO924290L (de)
NZ (1) NZ238089A (de)
PE (1) PE26691A1 (de)
PT (1) PT97616A (de)
RO (1) RO109450B1 (de)
TW (1) TW205549B (de)
WO (1) WO1991017163A1 (de)
YU (1) YU81191A (de)
ZA (1) ZA913497B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9102997D0 (en) * 1991-02-13 1991-03-27 Pfizer Ltd Therapeutic agents
AU5016793A (en) * 1992-08-20 1994-03-15 Cytomed, Inc Dual functional anti-inflammatory and immunosuppressive agents
US6372770B1 (en) 1994-10-12 2002-04-16 Euro-Celtique, S.A. Benzoxazoles
WO1999058518A2 (en) * 1998-05-12 1999-11-18 American Home Products Corporation Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
US6232322B1 (en) 1998-05-12 2001-05-15 American Home Products Corporation Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
US6310081B1 (en) 1999-05-10 2001-10-30 American Home Products Corporation Biphenyl sulfonyl aryl carboxylic acids useful in the treatment of insulin resistance and hyperglycemia
GB0302094D0 (en) 2003-01-29 2003-02-26 Pharmagene Lab Ltd EP4 receptor antagonists
GB0324269D0 (en) 2003-10-16 2003-11-19 Pharmagene Lab Ltd EP4 receptor antagonists
JP2016537398A (ja) 2013-09-13 2016-12-01 コーテンドー エービー(ピーユービーエル)Cortendo Ab(Publ) 新規なチトクロムp450阻害剤及びこれらの使用方法
CN105348182B (zh) * 2014-08-24 2018-04-13 复旦大学 2‑烷氧基苯甲酰芳胺类化合物及其药物用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES517193A0 (es) * 1981-11-10 1983-12-01 Wellcome Found Un procedimiento para la preparacion de nuevos derivados de imidazo (4,5-c)piridina.
GB8804439D0 (en) * 1988-02-25 1988-03-23 Pfizer Ltd Dihydropyridines
GB8822170D0 (en) * 1988-09-21 1988-10-26 Pfizer Ltd Therapeutic agents

Also Published As

Publication number Publication date
NO924290D0 (no) 1992-11-06
JPH0678340B2 (ja) 1994-10-05
EP0533695A1 (de) 1993-03-31
DE69104481D1 (de) 1994-11-10
MY105512A (en) 1994-10-31
JPH05505619A (ja) 1993-08-19
RO109450B1 (ro) 1995-02-28
CA2080476A1 (en) 1991-11-10
AP224A (en) 1992-10-27
NZ238089A (en) 1992-10-28
EP0533695B1 (de) 1994-10-05
AU642265B2 (en) 1993-10-14
HUT62894A (en) 1993-06-28
GT199100031A (es) 1992-10-30
AU7867191A (en) 1991-11-27
MA22151A1 (fr) 1991-12-31
FI925053A0 (fi) 1992-11-06
ES2061247T3 (es) 1994-12-01
PE26691A1 (es) 1991-10-21
YU81191A (sh) 1994-06-10
IE911553A1 (en) 1991-11-20
FI925053A (fi) 1992-11-06
DK0533695T3 (da) 1995-01-09
BR9106433A (pt) 1993-05-04
NO924290L (no) 1992-11-06
IL98075A0 (en) 1992-06-21
PT97616A (pt) 1992-03-31
WO1991017163A1 (en) 1991-11-14
ZA913497B (en) 1992-12-30
ATE112567T1 (de) 1994-10-15
AP9100259A0 (en) 1991-07-31
TW205549B (de) 1993-05-11
HU9203496D0 (en) 1993-01-28
CN1057839A (zh) 1992-01-15

Similar Documents

Publication Publication Date Title
MX9202838A (es) Imidazo[1,5-a]quinoxalinas.
DE577388T1 (de) Erdbewegungsmaschine.
MX9101597A (es) Arreglo de toallas,intercaladas,dobladas en l
DE69011914T2 (de) Olefinisch substitierte 1H-Imidazo[4,5-c]chinolin-4-amine.
NO911534D0 (no) Pyridinderivater.
DE69108784D1 (de) Schlüsselloses Spannfutter.
DE3877491D1 (de) Polysaccharid-/perfluoralkyl-komplexverbindungen.
DE59009117D1 (de) [1,2,4] Triazolo [1,5-a]pyridine.
DE69104481D1 (de) Imidazo[4,5-c]pyridine als paf antagonisten.
DE3575926D1 (de) 1,6-naphthyridin-2(1h)-one brauchbar als kardiotonika.
ES1010758Y (es) Maquina-herramienta modular.
ITTO920650A1 (it) Gruppo integrato di fertirrigazione.
IT1240984B (it) Veicolo modulare.
GB2264115B (en) 1H-2-Methylimidazo(4,5-c)pyridinyl Derivatives as PAF Antagonists
FI913838A (fi) Komplexa fosfater.
ITNA910031A0 (it) Spallina multiuso accoppiabile.
IT234656Y1 (it) Gruppo costruttivo per cassetti.
DE69109538T2 (de) Kompakt-Mehrzweckepiskop.
FI923539A0 (fi) Modulariska byggnader.
DE69100646D1 (de) Bohrbearbeitungsvorrichtung.
NO911833D0 (no) Gulvsluk.
IT215643Z2 (it) Carrello modulare multiuso particolarmente per servizi igienici.
ES1010203Y (es) Atril-mesa polivalente.
IT9048079A1 (it) Veicolo sanitario di base polivalente.
IT9047304A1 (it) Fresatrice alternativa.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee